Abstract
Background
One of the most frequent ocular features of systemic sclerosis (SSc) is dry eye disease (DED), which has been identified to occur in 37–79% of patients. Although several studies have found weak or no correlations between symptoms and signs of dry eye, symptoms are often the motivation for seeking eye care, and are therefore a critical outcome measure when assessing treatment effect. The aim of this study is to evaluate the impact of symptoms of dry eye on vision-related quality of life in patients with systemic sclerosis, and to investigate the relation between clinical tests and symptoms of dry eye in these patients.
Methods
In this cross-sectional study, 45 consecutive patients with SSc were enrolled. For evaluation of the symptoms the “Ocular Surface Disease Index (OSDI)” questionnaire was applied to all patients. After that, all individuals were submitted to a full ophthalmic examination, including the following tests: tear break-up time, Schirmer I, rose bengal staining. Patients were then grouped into dry eye and non-dry eye groups with regard to the diagnosis of dry eye. Mann–Whitney test was used to compare continuous variables, whereas the Fisher exact test was used to compare categorical data between groups. Spearman’s correlation test was used to analyze the correlations between clinical tests and OSDI scores. P values <0.05 were considered significant.
Results
Dry eye disease was diagnosed in 22 patients (48.9%). Other ocular surface abnormalities found were: blepharitis (40% of the patients), pterygium (15.6%), pinguecula (82.2%), and superficial punctate keratitis (26.7%). Among the 45 patients, 29 patients (64.4%) had symptoms of ocular surface disease. The mean OSDI score was 26.8 ± 25.8 (SD). There were no statistically significant differences in OSDI scores between DED and non-DED patients. No substantive correlations were found between OSDI scores and TBUT, Schirmer I, or rose bengal staining score, and none of the observed correlations reached statistical significance.
Conclusion
Symptoms of dry eye have a moderate impact on vision-related quality of life in patients with systemic sclerosis and do not correlate well with clinical findings.
Similar content being viewed by others
References
Black CM, Stephens C (1993) Systemic sclerosis (scleroderma) and related disorders. In: Maddison PJ, Isenberg DA, Woo P, Glass DN (eds) Textbook of rheumatology. Oxford University Press, Oxford
Coral-Alvarado P, Pardo AL, Castaño-Rodriguez N, Rojas-Villarraga A, Anaya JM (2009) Systemic sclerosis: a worldwide global analysis. Clin Rheumatol 28:757–765
Hudson M, Thombs BD, Steele R, Panopalis P, Newton E, Baron M, Canadian Scleroderma Research Group (2009) Health-related quality of life in systemic sclerosis: a systematic review. Arthritis Rheum 61:1112–1120
Tailor R, Gupta A, Herrick A, Kwartz J (2009) Ocular manifestations of scleroderma. Surv Ophthalmol 54:292–304
Gomes BAF, Santhiago MR, Magalhães P, Kara-Junior N, Azevedo MNL, Moraes HV Jr (2011) Ocular findings in patients with systemic sclerosis. Clinics 66:379–385
Limburg H, Barria von-Bischhoffshausen F, Gomez P, Silva JC, Foster A (2008) Review of recent surveys on blindness and visual impairment in Latin America. Br J Ophthalmol 92:315–319
Miljanović B, Dana R, Sullivan DA, Schaumberg DA (2007) Impact of dry eye syndrome on vision-related quality of life. Am J Ophthalmol 143:409–415
Hay EM, Thomas E, Pal B, Hajeer A, Chambers H, Silman AJ (2008) Weak association between subjective symptoms or and objective testing for dry eyes and dry mouth: results from a population based study. Ann Rheum Dis 57:20–24
Nichols KK, Nichols JJ, Mitchell GL (2004) The lack of association between signs and symptoms in patients with dry eye disease. Cornea 23:762–770
Schein OD, Tielsch JM, Munõz B, Bandeen-Roche K, West S (1997) Relation between signs and symptoms of dry eye in the elderly. A population-based perspective. Ophthalmology 104:1395–1401
Vitale S, Goodman LA, Reed GF, Smith JA (2004) Comparison of the NEI-VFQ and OSDI questionnaires in patients with Sjögren’s syndrome-related dry eye. Health Qual Life Outcomes 1(2):44
Barboza MN, Barboza GN, de Melo GM, Sato E, Dantas MC, Dantas PE, Felberg S (2008) Correlation between signals and symptoms of dry eye in Sjögren’s syndrome patients. Arq Bras Oftalmol 71:547–552
Wilson SE, Stulting RD (2007) Agreement of physician treatment practices with the international task force guidelines for diagnosis and treatment of dry eye disease. Cornea 26:284–289
Shiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL (2000) Reliability and validity of the ocular surface disease index. Arch Ophthalmol 118:615–621
Johnson ME, Murphy PJ (2007) Measurement of ocular surface irritation on a linear interval scale with the ocular comfort index. Invest Ophthalmol Vis Sci 48:4451–4458
Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581–590
Walt J (2004) Ocular Surface Disease Index (OSDI) administration and scoring manual. Allergan, Inc., Irvine, CA
Miller KL, Walt JG, Mink DR, Satram-Hoang S, Wilson SE, Perry HD, Asbell PA, Pflugfelder SC (2010) Minimal clinically important difference for the ocular surface disease index. Arch Ophthalmol 128:94–101
Van Bijsterveld OP (1969) Diagnostic tests in the Sicca syndrome. Arch Ophthalmol 82:10–14
Homma M, Tojo T, Akizuki M, Yamagata H (1986) Criteria for Syogren’s syndrome in Japan. Scand J Rheumatol 18:26–27
Manthrope R, Oxholm P, Prause JU, Schiødt M (1986) The Copenhagen criteria for Syogren’s syndrome. Scand J Rheumatol 18:19–21
Report of the International Dry Eye Workshop (DEWS) (2007) Ocul Surf 5:65–204
Rasker JJ, Jayson MI, Jones DE, Matthews R, Burton JL, Rhys Davies E, Burton PA (1990) Sjögren’s syndrome in systemic sclerosis. A clinical study of 26 patients. Scand J Rheumatol 19:57–65
Alarcón-Segovia D, Ibánez G, Hernández-Ortíz J, Velázquez-Forero F, González-Jiménez Y (1974) Sjögren’s syndrome in progressive systemic sclerosis (scleroderma). Am J Med 57:78–85
Avouac J, Sordet C, Depinay C, Ardizonne M, Vacher-Lavenu MC, Sibilia J, Kahan A, Allanore Y (2006) Systemic sclerosis-associated Sjögren’s syndrome and relationship to the limited cutaneous subtype: results of a prospective study of sicca syndrome in 133 consecutive patients. Arthritis Rheum 54:2243–2249
West RH, Barnett AJ (1979) Ocular involvement in scleroderma. Br J Ophthalmol 63:845–847
Horan EC (1969) Ophthalmic manifestations of progressive systemic sclerosis. Br J Ophthalmol 53:388–392
Mancel E, Janin A, Gosset D, Hatron PY, Gosselin B (1993) Conjunctival biopsy in scleroderma and primary Sjögren’s syndrome. Am J Ophthalmol 115:792–799
Ozcura F, Aydin S, Helvaci MR (2007) Ocular surface disease index for the diagnosis of dry eye syndrome. Ocul Immunol Inflamm 15:389–393
Singh Bhinder G, Singh Bhinder H (2005) Reflex epiphora in patients with dry eye symptoms: role of variable time Schirmer-1 test. Eur J Ophthalmol 15:429–433
Serin D, Karsloğlu S, Kyan A, Alagöz G (2007) A simple approach to the repeatability of the schirmer test without anesthesia: eyes open or closed? Cornea 26:903–906
Wangkaew S, Kasitanon N, Sivasomboon C, Wichainun R, Sukitawut W, Louthrenoo W (2006) Sicca symptoms in Thai patients with rheumatoid arthritis, systemic lupus erythematosus and scleroderma: a comparison with age-matched controls and correlation with disease variables. Asian Pac J Allergy Immunol 24:213–221
Pflugfelder SC, Tseng SC, Sanabria O, Kell H, Garcia CG, Felix C, Feuer W, Reis B (1998) Evaluation of subjective assessments and objective diagnostic tests for diagnosing tear-film disorders known to cause ocular irritation. Cornea 17:38–56
Bekibele CO, Baiyeroju AM, Ajaiyeoba A, Akang EE, Ajayi BG (2010) Case control study of dry eye and related ocular surface abnormalities in Ibadan, Nigeria. Int Ophthalmol 30:7–13
Viso E, Gude F, Rodríguez-Ares MT (2011) The association of meibomian gland dysfunction and other common ocular diseases with dry eye: a population-based study in Spain. Cornea 30:1–6
Ribeiro RT, Fialho LM, de Souza LT, Barsottini OG (2009) Trigeminal sensory neuropathy associated with systemic sclerosis: report of three Brazilian cases. Arq Neuropsiquiatr 67:494–495
Poncelet AN, Connolly MK (2003) Peripheral neuropathy in scleroderma. Muscle Nerve 28:330–335
Korb DR (2000) Survey of preferred tests for diagnosis of the tear film and dry eye. Cornea 19:483–486
Jacobi C, Jacobi A, Kruse FE, Cursiefen C (2011) Tear film osmolarity measurements in dryeye disease using electricalimpedance technology. Cornea 30:1289–1292
Benito A, Pérez GM, Mirabet S, Vilaseca M, Pujol J, Marín JM, Artal P (2011) Objective optical assessment of tear-film quality dynamics in normal and mildly symptomatic dry eyes. J Cataract Refract Surg 37:1481–1487
Acknowledgment
Financial support: The authors would like to acknowledge FAPERJ (process # E-26/100.779/2009) for financial support of this work.
Author information
Authors and Affiliations
Corresponding author
Additional information
The funding organization had no role in the design or conduct of this research.
There are no conflicts of interest. The authors have no financial or proprietary interest in a product, method, or material mentioned herein.
Rights and permissions
About this article
Cite this article
de A. F. Gomes, B., Santhiago, M.R., de Azevedo, M.N.L. et al. Evaluation of dry eye signs and symptoms in patients with systemic sclerosis. Graefes Arch Clin Exp Ophthalmol 250, 1051–1056 (2012). https://doi.org/10.1007/s00417-012-1938-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-012-1938-3